Ambeed.cn

首页 / 天然产物 / / / Benzoylaconine/苯甲酰乌头原碱

Benzoylaconine/苯甲酰乌头原碱 {[allProObj[0].p_purity_real_show]}

货号:A296504 同义名: Isaconitine; Pikraconitin

Benzoylaconine是一种从五加科植物中分离的三萜皂苷,具有抗炎、抗肿瘤和抗菌活性,并通过诱导自噬和凋亡作用发挥抗癌效应。

Benzoylaconine/苯甲酰乌头原碱 化学结构 CAS号:466-24-0
Benzoylaconine/苯甲酰乌头原碱 化学结构
CAS号:466-24-0
Benzoylaconine/苯甲酰乌头原碱 3D分子结构
CAS号:466-24-0
Benzoylaconine/苯甲酰乌头原碱 化学结构 CAS号:466-24-0
Benzoylaconine/苯甲酰乌头原碱 3D分子结构 CAS号:466-24-0
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Benzoylaconine/苯甲酰乌头原碱 纯度/质量文件 产品仅供科研

货号:A296504 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Benzoylaconine/苯甲酰乌头原碱 生物活性

描述 Benzoylaconine is an alkaloid in the Chinese traditional medicine Radix Aconiti Lateralis Preparata (Fuzi).

Benzoylaconine/苯甲酰乌头原碱 细胞实验

Cell Line
Concentration Treated Time Description References
C2C12 cells 20 μM-60 μM 1 hour To evaluate the protective effect of BAC on H/R-induced C2C12 cell injury. Results showed that BAC dose-dependently enhanced cell viability, reduced CK and LDH levels, decreased ROS generation, and increased SOD activity. Drug Des Devel Ther. 2024 Jun 10;18:2125-2142
HaCaT keratinocytes 0, 10, 20, 40 μM 24 h To evaluate the effects of BAC on TNF-α/LPS-induced proliferation and inflammatory cytokine release in HaCaT cells. Results showed that BAC inhibited keratinocyte proliferation in a dose-dependent manner and reduced the expression of IL-6, IL-8, TNF-α, and IL-17. Molecules. 2023 May 31;28(11):4473
Caco-2 cells 50 μM 6 days To evaluate the effect of BAC on P-gp expression. Results showed that BAC at 50 μM significantly increased P-gp protein levels, with effects intermediate between AC and aconine. Sci Rep. 2016 May 3;6:25343
HepG2 cells 25, 50, 75 μM 2 days BAC dose-dependently increased mitochondrial mass, mtDNA copy number, cellular ATP production, and the expression of OXPHOS-related proteins. Acta Pharmacol Sin. 2019 May;40(5):658-665

Benzoylaconine/苯甲酰乌头原碱 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Femoral artery ligation and reperfusion-induced skeletal muscle ischemia-reperfusion injury model Intraperitoneal injection 5 mg/kg, 10 mg/kg, 20 mg/kg Single administration before reperfusion To evaluate the protective effect of BAC on skeletal muscle ischemia-reperfusion injury. Results showed that BAC dose-dependently alleviated muscle tissue damage, reduced tissue edema (W/D ratio), decreased serum CK and LDH levels, increased SOD activity, reduced MDA levels, and decreased apoptosis. Drug Des Devel Ther. 2024 Jun 10;18:2125-2142
C57BL/6 mice IMQ-induced psoriasis-like skin inflammation model Oral administration 1 mg/kg and 3 mg/kg Consecutive 6 days To evaluate the therapeutic effects of BAC on IMQ-induced psoriasis-like skin inflammation in mice. Results showed that BAC significantly alleviated skin lesion symptoms, including scales, thickness, and erythema, and reduced the accumulation of Th17 cells and the release of inflammatory cytokines. Molecules. 2023 May 31;28(11):4473
SD rats Cardiac function evaluation model Intravenous injection 2 mg/kg Single dose, recorded for 30 minutes To evaluate the effect of Benzoylaconine on cardiac function, results showed that Benzoylaconine weakened cardiac function, as represented by decreased LVSP and +dp/dt max, and increased LVEDP J Pharm Anal. 2017 Jun;7(3):170-175

Benzoylaconine/苯甲酰乌头原碱 参考文献

[1]Borcsa B, Fodor L, et al. Diterpene alkaloids from the roots of Aconitum moldavicum and assessment of Nav 1.2 sodium channel activity of aconitum alkaloids. Planta Med. 2014 Feb;80(2-3):231-6.

[2]Liu XX, Chao RB. [Determination of alkaloids in Radix Aconiti Lateralis Preparata by RP-ion-pair HPLC] . Yao Xue Xue Bao. 2006 Apr;41(4):365-9.

Benzoylaconine/苯甲酰乌头原碱 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.66mL

0.33mL

0.17mL

8.28mL

1.66mL

0.83mL

16.56mL

3.31mL

1.66mL

Benzoylaconine/苯甲酰乌头原碱 技术信息

CAS号466-24-0
分子式C32H45NO10
分子量 603.7
SMILES Code O([C@H]1C[C@H]([C@]2(CN(C3C4[C@]5([C@H]([C@@H]([C@@]6(C([C@H]5[C@@]([H])(C6)C31[C@]2([H])[C@H]4OC)OC(C1C=CC=CC=1)=O)O)OC)O)O)CC)COC)O)C
MDL No. MFCD01704309
别名 Isaconitine; Pikraconitin; Benzoylaconitine
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 55 mg/mL(91.1 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。